PALLIATIVE CARE DAY: OCTOBER 9, 2021
Advancing the Practice of Personalized Palliative Radiotherapy
CyberKnife hypofractionated stereotactic radiosurgery (CyberKnife-hSRS) as salvage treatment for brain metastases
Hypofractionated stereotactic radiosurgery using CyberKnife is an important salvage treatment for cerebral metastases including pre-irradiated cases.
Local Tumor Control for Metastatic Epidural Spinal Cord Compression Following Separation Surgery with Adjuvant CyberKnife Stereotactic Radiotherapy or Image-Guided Intensity-Modulated Radiotherapy
Hybrid surgery/CyberKnife radiosurgery therapy is a safe and effective treatment option for patients with metastatic epidural spinal cord compression, demonstrating high local control rates.
CyberKnife Stereotactic Radiosurgery for Cholangiocarcinoma
CyberKnife demonstrated favorable results as a successful non-invasive palliative treatment for a patient with advanced cancer seeking an alternative therapy to improve her QoL.
CyberKnife is a promising, non-invasive, palliative treatment with acceptable toxicity for locally advanced unresectable and metastatic pancreatic cancer
Helical TomoTherapy for chemo-refractory multiple liver metastases.
Helical TomoTherapy for chemo-refractory multiple liver metastases proves to be a feasible and effective treatment.
Local radiotherapy for pleural dissemination of thymic tumors after initial treatment.
Multiple pleural lesions can be effectively and safely treated with TomoTherapy demonstrating good local control and overall survival.
Adjuvant helical TomoTherapy was effective and well tolerated in a case of locally advanced breast cancer with extensive cutaneous metastases.
Expanding Access to Personalized Palliative Radiotherapy
Connect with Accuray to get the answers you need.